We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Biogen Idec Inc. (BIIB) and Biovitrum AB (BIOVY, BVT.SK) said they will move ahead in testing their protein treatment for a type of hemophilia after it was well tolerated in an earlier study. The...
Biogen Idec Inc. (BIIB) extended its tender offer for Facet Biotech Corp. (FACT) shares by nearly two months to Dec. 16, despite Facet's repeated insistence that it has no interest in the $356...
Facet Biotech Corp. (FACT) told shareholders not to tender their holdings for Biogen Idec Inc.'s (BIIB) $356 million takeover offer and disclosed that it has received inquiries from third parties...
Drug developer Facet Biotech Corp. (FACT) told its shareholders Thursday not to tender their holdings to Biogen Idec Inc.'s (BIIB) $356 million takeover offer, a bid the company had already called...
(Adds response from Facet's board and updates stock quotes, in the third and last paragraphs.) DOW JONES NEWSWIRES Biogen Idec Inc. (BIIB) launched its $356 million tender offer for Facet Biotech...
Biogen Idec Inc. (BIIB) launched its $356 million tender offer for Facet Biotech Corp. (FACT), taking directly to shareholders a takeover bid repeatedly rejected by the company. Facet, a cash-rich...
Facet Biotech Corp. (FACT) again shunned Biogen Idec Inc.'s (BIIB) approaches Tuesday, calling its $356 million takeover offer "inadequate" and "not in the best interest" of shareholders. The...
Facet Biotech Corp. (FACT) again shunned Biogen Idec Inc.'s (BIIB) approaches Tuesday, calling its $356 million takeover offer "inadequate" and "not in the best interest" of shareholders. The...
Facet Biotech Corp. (FACT) again shunned Biogen Idec Inc.'s (BIIB) approaches Tuesday, calling its $356 million takeover offer "inadequate" and "not in the best interest" of shareholders. The...
Drug developer Facet Biotech Corp. (FACT) again shunned Biogen Idec Inc.'s (BIIB) approaches, on Tuesday calling its $356 million takeover offer "inadequate" and "not in the best interest" of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions